Phase 2b Controlled Study

NCT07140380 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: IVW-1001 Ophthalmic Eyelid Wipe

Sponsor

IVIEW Therapeutics Inc.